Literature DB >> 8776312

Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study.

J Merlo, J Ranstam, H Liedholm, B Hedblad, G Lindberg, U Lindblad, S O Isacsson, A Melander, L Råstam.   

Abstract

OBJECTIVE: To analyse the association between use of antihypertensive treatment, diastolic blood pressure, and long term incidence of ischaemic cardiac events in elderly men.
DESIGN: Population based cohort study. Baseline examination in 1982-3 and follow up for up to 10 years.
SETTING: Malmŏ, Sweden.
SUBJECTS: 484 randomly selected men born in 1914 and living in Malmŏ during 1982. MAIN OUTCOME MEASURES: Observational comparisons of incidence rates and rate and hazard ratios of ischaemic cardiac events (myocardial infarction or death due to chronic ischaemic cardiac disease).
RESULTS: The crude incidence rate of ischaemic cardiac events was higher in those subjects who were taking antihypertensive drugs than in those who were not (rate ratio 2.6 (95% confidence interval 1.7 to 3.9)). After adjustment for potential confounders (differences in baseline smoking habits, blood pressure, time since diagnosis of hypertension, ischaemic or other cardiovascular disease, hypercholesterolaemia, hypertriglyceridaemia, diabetes mellitus, obesity, and raised serum creatinine concentration) this rate was reduced but still raised (hazard ratio 1.9 (1.0 to 3.7)). In men with diastolic blood pressure > 90 mm Hg, antihypertensive treatment was associated with a twofold increase in the incidence of ischaemic cardiac events (rate ratio 2.0 (1.1 to 3.6)), which vanished after adjustment for potential confounders (hazard ratio 1.1 (0.5 to 2.6)). In those subjects with diastolic blood pressure < or = 90 mm Hg, antihypertensive treatment was associated with fourfold increase in incidence (rate ratio 3.9 (2.1 to 7.1)), which remained after adjustment for potential confounders (hazard ratio 3.8 (1.3 to 11.0)).
CONCLUSION: Antihypertensive treatment may increase the risk of myocardial infarction in elderly men with treated diastolic blood pressures < or = 90 mm Hg.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8776312      PMCID: PMC2351832          DOI: 10.1136/bmj.313.7055.457

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  13 in total

1.  Blood pressure and mortality: an epidemiological survey with 10 years follow-up.

Authors:  J Clausen; G Jensen
Journal:  J Hum Hypertens       Date:  1992-02       Impact factor: 3.012

2.  Hazard of obesity--the Norwegian experience.

Authors:  H T Waaler
Journal:  Acta Med Scand Suppl       Date:  1988

3.  Different social network and social support characteristics, nervous problems and insomnia: theoretical and methodological aspects on some results from the population study 'men born in 1914', Malmö, Sweden.

Authors:  B S Hanson; P O Ostergren
Journal:  Soc Sci Med       Date:  1987       Impact factor: 4.634

4.  Hypertension and ST segment depression during ambulatory electrocardiographic recording. Results from the prospective population study 'men born in 1914' from Malmö, Sweden.

Authors:  B Hedblad; L Janzon
Journal:  Hypertension       Date:  1992-07       Impact factor: 10.190

5.  Blood pressure change and survival after age 75.

Authors:  R D Langer; M H Criqui; E L Barrett-Connor; M R Klauber; T G Ganiats
Journal:  Hypertension       Date:  1993-10       Impact factor: 10.190

6.  Factors influencing participation in health surveys. Results from prospective population study 'Men born in 1914' in Malmö, Sweden.

Authors:  L Janzon; B S Hanson; S O Isacsson; S E Lindell; B Steen
Journal:  J Epidemiol Community Health       Date:  1986-06       Impact factor: 3.710

7.  The impact of elevated blood pressure upon 10-year mortality among Japanese men in Hawaii: the Honolulu Heart Program.

Authors:  K Yano; D McGee; D M Reed
Journal:  J Chronic Dis       Date:  1983

8.  Benefits and potential harm of lowering high blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

Review 9.  Optimising diuretic therapy in elderly patients with hypertension.

Authors:  W C Cushman
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

10.  The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?

Authors:  L Farnett; C D Mulrow; W D Linn; C R Lucey; M R Tuley
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

View more
  7 in total

1.  Treating hypertension: the evidence from clinical trials.

Authors:  J A Simon
Journal:  BMJ       Date:  1996-08-24

2.  Treating hypertension in elderly people. Statistics cannot eliminate weaknesses in study design.

Authors:  M Hoffmann; J Ahlner
Journal:  BMJ       Date:  1996-12-07

Review 3.  Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.

Authors:  Ian A Scott; Sarah N Hilmer; David G Le Couteur
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

Review 4.  Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety Margin.

Authors:  Goran Koracevic; Milovan Stojanovic; Tomislav Kostic; Dragan Lovic; Miloje Tomasevic; Ruzica Jankovic-Tomasevic
Journal:  Med Princ Pract       Date:  2020-05-07       Impact factor: 1.927

5.  The management of hypertension in the elderly by general practitioners in Merseyside: the rule of halves revisited.

Authors:  M Cranney; S Barton; T Walley
Journal:  Br J Gen Pract       Date:  1998-04       Impact factor: 5.386

6.  Exclusion and inclusion of nonwhite ethnic minority groups in 72 North American and European cardiovascular cohort studies.

Authors:  Meghna Ranganathan; Raj Bhopal
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

7.  Serious adverse events in patients with target-oriented blood pressure management: a systematic review.

Authors:  Lukas Frey; Isaac Gravestock; Giuseppe Pichierri; Johann Steurer; Jakob M Burgstaller
Journal:  J Hypertens       Date:  2019-11       Impact factor: 4.844

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.